AstraZeneca PLC (LON:0A4J)
London · Delayed Price · Currency is GBP · Price in USD 67.00
+0.17 (0.25%)
At close: Apr 22, 2025
MorphoSys AG Market Cap
AstraZeneca has a market cap or net worth of 169.80 billion as of August 8, 2025. Its market cap has decreased by -11.41% in one year.
Market Cap
169.80B
Enterprise Value
188.72B
Revenue
41.24B
Ranking
n/a
PE Ratio
28.05
Stock Price
$67.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 169.80B, an increase of 3,631.53%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 169.80B | 4.63% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | 96.14B | -3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.80B |
| HSBC Holdings | 161.93B |
| Shell | 155.68B |
| Unilever | 112.71B |
| British American Tobacco p.l.c. | 91.53B |
| Rolls-Royce Holdings | 91.50B |
| Rio Tinto Group | 76.62B |
| RELX PLC | 67.05B |